Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 25, Issue 3, 2003, Pages 209-213

  Zacharieva, Sabina ^a   Shigarminova, R ^a   Nachev, E ^a   Kamenov, Z ^a   Atanassova, I ^a   Orbetzova, M ^a   Stoynev, A ^a   Doncheva, N ^a   Borissova A M , ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Amlodipine; Blood pressure; Bone markers; Hormone replacement therapy; Menopause

Indexed keywords

ALKALINE PHOSPHATASE; AMLODIPINE BESYLATE; CALCIUM; CHOLESTEROL; DEOXYPYRIDINOLINE; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; OSTEOCALCIN; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BONE METABOLISM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0038324161     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2003.25.3.769642     Document Type: Article

References (28)

1. Staessen, J.A., Celis, H., Fagard, R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998, 12: 587-92.
2. Szekacs, B., Vajo, Z., Acs, N. et al. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with hypertension. Menopause 2000, 7: 31-5.
3. Harrison-Bernard, L.M., Raij, L. Postmenopausal hypertension. Curr Hypertens Rep 2000, 2(2): 202-7.
4. Kloner, R.A., Sowers, J.R., DiBona, G.F., Gaffney, M., Wein, M. Sex-and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 1996, 77(9): 713-22.
5. Agabiti-Rosei, E., Ambrosioni, E., Pirelli, A., Stimpel, M., Zanchetti, A. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. The MADAM study group. Eur J Clin Pharcamol 1999, 55: 185-9.
6. Tulenko, T.N., Sumner, A.E., Chen, M., Huang, Y., Laury-Kleintop, L., Ferdinand, F.D. The smooth muscle cell membrane during atherogenesis: A potential target for amlodipine in atheroprotection. Am Heart J 2001, 141 (2 Suppl.): S1-11.
7. Kloner, R.A., Weinberger, M., Pool, J.L. et al. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy. (CASTLE) Study Investigators. Am J Cardiol 2001, 87(6): 727-31.
8. Boesgaard, S., Hyldstrup, L., Feldstedt, M. Changes in calcium homoeostasis and bone formation in patients recovering from acute myocardial infarction: Effect of verapamil treatment. Danish Study Group on Verapamil in Myocardial Infarction. Eur J Clin Pharmacol 1991, 41(6): 521-3.
9. Sjoden, G., Rosenqvist, M., Nordenstrom, J., Bjorkhem, I., Eriksson, S.A., Kriegholm, E. Verapamil increases serum ionized calcium and serum phosphate in patients with post-surgical hypoparathyroidism. Eur J Clin Invest 1992, 22(6): 378-82.
10. Halberg, F., Johnson, E.A., Nelson, W., Runge, W., Sothern, R. Autorhythmometry - procedures for physiologic self-measurements and their analysis. Physiology Teacher 1972, 1: 1-11.
11. Staessen, J.A., Ginocchio, G., Thijs, L., Fagard, R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997, 11: 507-14.
12. Langdon, C. Treatment of hypertension in patients > or = 65 years of age: Experience with amlodipine. Clin Ther 2000, 22(12): 1473-82.
13. Terpstra, W.F., May, J.F., Smit, A.J. et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: The ELVERA trial. J Hypertens 2001, 19(2): 303-9.
14. Germano, G., Ramponi, C., Caparra, A. et al. Comparative study of the effects of amlodipine and nitrendipine on 24-hour blood pressure profile. Clin Drug Invest 1997, 13 (Suppl. 1): 77-82. ISSN: 1173-2563.
15. Punzi, H.A., Noveck, R., Weiss, R.J. et al. Are there differences in the effects of long-acting calcium antagonists on ambulatory blood pressure? Extended-release nisoldipine versus amlodipine as a model. Blood Press Monit 1998, 3(4): 267-72.
16. Hernandez Hernandez, R., Armas-Hernandez, M.J., Chourio, J.A. et al. Comparative effects of amlaodipine and nifedipine GITS during treatment and after missing two doses. Blood Press Monit 2001, 6(1): 47-57.
17. Mercuro, G., Zoncu, S., Piano, D. et al. Estradiol-17β recues blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998, 1 (18 Part 1): 909-13.
18. Hassager, C., Christiansen, C. Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women. Maturitas 1988, 9(4): 315-23.
19. Tatti, P., Pahor, M., Byington, R.P. et al. Outcome results of the Fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998, 21(4): 597-603.
20. O'Neill, TW., Silman, A.J., Navez Diaz, M., Cooper, C., Kanis, J., Felsenberg, D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporosis Inernat 1997, 7: 72-8.
21. Redlich, K., Pietschmann, P., Stulc, T., Peterlik, M. Comparative study on the effect of calcium channel blockers on basal and parathyroid hormone-induced bone resorption in vitro, Pharmacol Toxicol 1997, 80(6): 262-5.
22. Zofkova, I., Kancheva, R.L. The effect of nifedipine on serum parathyroid hormone and calcitonin in postmenopausal women. Life Sci 1995, 57(11): 1087-96.
23. Boesgaard, S., Hyldstrup, L., Feldstedt, M. Changes in calcium homoeostasis and bone formation in patients recovering from acute myocardial infarction: Effect of verapamil treatment. Danish Study Group on Verapamil in Myocardial Infarction. Eur J Clin Pharmacol 1991, 41(6): 521-3.
24. Albers, M.M., Johnson, W., Vivian, V., Jackson, R.D. Chronic use of the calcium channel blocker nifedipine has no significant effect on bone metabolism in men. Bone 1991, 12(1): 39-42.
25. Watts, N.B., Nolan, J.C., Brennan, J.J., Yang, H.M. Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: A two-year study. ESTRATAB/Osteoporosis Study Group. Menopause 2000, 7(6): 375-82.
26. Fiore, C.E., Pennisi, P., Tandurella, F.G. et al. Response of biochemical markers of bone turnover to estrogen treatment in postmenopausal women: Evidence against an early anabolic effect on bone formation. J Endocrinol Invest 2001, 24: 423-29.
27. Tobias, J.H., Compston, J.E. Does estrogen stimulate osteoblast function in postmenopausal women? Bone 1999, 14: 121-4.
28. Wahab, M., Ballard, P., Purdie, D.W., Cooper, A., Wilson, J.C. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynaecol 1997, 104: 728-31.